Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial)

@inproceedings{Dauvissat2018SafetyAP,
  title={Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid in Patients with Trapeziometacarpal Osteoarthritis. Results of a Multicentre Prospective Open-Label Pilot Study (INSTINCT Trial)},
  author={J{\'e}r{\'e}my Dauvissat and Christophe Rizzo and Henri Lellouche and J{\'e}r{\^o}me Porterie and Sylvie Melac-Ducamp and Vincent Locquet and Vincent Travers and Bernard Maillet and Thierry Conrozier},
  booktitle={Clinical medicine insights. Arthritis and musculoskeletal disorders},
  year={2018}
}
Purpose To assess safety and search predictive factors of efficacy of a single intra-articular injection of a mannitol-modified hyaluronic acid (HA) viscosupplement, in patients having trapeziometacarpal (TMC) osteoarthritis (OA). Methods Patients with symptomatic TMC OA, not adequately relieved by analgesic therapy and/or by the use of a thumb splint, were included in a 3-month prospective multicentre open-label trial. All underwent plain radiographs with the Kapandji incidences allowing the… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 60 REFERENCES

Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: a meta-analysis

He W-W, Kuang M-J, J Zhao
  • Int J Surg Lond Engl. 2017;39:95–103
  • 2017